Petros Pharmaceuticals, Inc. (PTPI) › Net IncomePetros Pharmaceuticals, Inc. (PTPI) — Net IncomeAnnual figures by period end, from SEC filings.2020-12-31: -$20.59M2021-12-31: -$8.99M2022-12-31: -$20.04M2023-12-31: -$8.16M2024-12-31: -$14.32M2025-12-31: $1.91M$1.91M2020-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31$1.91M—2026-04-15From 2025-01-012024-12-31-$14.32M—2026-04-15From 2024-01-012023-12-31-$8.16M—2025-03-31From 2023-01-012022-12-31-$20.04M—2024-04-01From 2022-01-012021-12-31-$8.99M—2023-03-31From 2021-01-012020-12-31-$20.59M—2022-03-31From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)